^
CANCER:

Merkel Cell Carcinoma

Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
No biomarker
Merkel Cell Carcinoma
avelumab
Sensitive
:
A1
No biomarker
Merkel Cell Carcinoma
pembrolizumab
Sensitive
:
A1
No biomarker
Merkel Cell Carcinoma
EP
Sensitive
:
A2
No biomarker
Merkel Cell Carcinoma
nivolumab
Sensitive
:
A2
No biomarker
Merkel Cell Carcinoma
cisplatin
Sensitive
:
A2
No biomarker
Merkel Cell Carcinoma
carboplatin
Sensitive
:
A2
No biomarker
Merkel Cell Carcinoma
carboplatin + etoposide oral
Sensitive
:
A2
No biomarker
Merkel Cell Carcinoma
topotecan
Sensitive
:
A2
No biomarker
Merkel Cell Carcinoma
CAV
Sensitive
:
A2
No biomarker
Merkel Cell Carcinoma
AST-008
Sensitive
:
B
ARID2 mutation
Merkel Cell Carcinoma
Immunotherapy
Sensitive
:
C3
NTRK1 mutation
Merkel Cell Carcinoma
Immunotherapy
Sensitive
:
C3
PD-L1 expression
Merkel Cell Carcinoma
avelumab
Sensitive
:
C3
PD-1 expression
Merkel Cell Carcinoma
Immunotherapy
Sensitive
:
C3
TP53 wild-type
Merkel Cell Carcinoma
KRT-232
Sensitive
:
C3
DLL3 expression
Merkel Cell Carcinoma
rovalpituzumab tesirine
Sensitive
:
C4
PD-L1 negative
Merkel Cell Carcinoma
avelumab
Sensitive
:
C4
NCAM1 expression
Merkel Cell Carcinoma
nivolumab
Sensitive
:
C4
NKX2-1 expression
Merkel Cell Carcinoma
avelumab
Sensitive
:
C4
TP53 wild-type
Merkel Cell Carcinoma
RAIN-32
Sensitive
:
D